Astellas Pharma (4503.T) Net Income

Price: $1435
Market Cap: $2.57T
Avg Volume: 6.89M
Country: JP
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.166
52W Range: $1243.5-1835
Website: Astellas Pharma

What is Astellas Pharma's Net Income?

  • Astellas Pharma's annual net income as of FY 2023 is $17.05B.
  • Astellas Pharma's quarterly net income as of Q3 2024 is $-97.66B.

What is Net Income?

Net income is the total profit of a company after all expenses and taxes have been deducted from revenue. It is also known as net profit or net earnings and is a key indicator of a company's financial performance and profitability.

Related Metrics

Other important metrics to assess Astellas Pharma's financial health include:

  • Net Income Growth - the rate at which a company's net income is growing:
    • Annual Growth: -82.73%
  • Net Income Ratio - net income divided by revenue:
    • Annual: 1.06%
    • Quarterly: -18.87%
  • Net Income Per Share - net income divided by the number of shares outstanding:
    • Annual: $9.50

These metrics provide insights into Astellas Pharma's financial health and its profitability. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Net Income

$17.05B

Quarterly Net Income

$-97.66B

Historical Annual Net Income
$240.00B$240.00B$180.00B$180.00B$120.00B$120.00B$60.00B$60.00B$0.00$0.00Net Income (Annual)201620162017201720182018201920192020202020212021202220222023202320242024
Historical Quarterly Net Income
$100.00B$100.00B$50.00B$50.00B$0.00$0.00-$50.00B-$50.00B-$100.00B-$100.00BNet Income (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Annual Net Income Growth
88.09%88.09%31.15%31.15%-25.79%-25.79%-82.73%-82.73%Net Income Growth (%)201620162017201720182018201920192020202020212021202220222023202320242024
Annual Net Income Per Share
$120.00$120.00$90.00$90.00$60.00$60.00$30.00$30.00$0.00$0.00Net Income Per Share201620162017201720182018201920192020202020212021202220222023202320242024

Astellas Pharma Historical Net Income Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Net Income Net Income Growth Net Income Ratio Net Income Per Share
2024 $17.05B -82.73% 1.06% $9.50
2023 $98.71B -20.45% 6.50% $54.24
2022 $124.09B 2.90% 9.57% $67.08
2021 $120.59B -38.29% 9.65% $64.93
2020 $195.41B -12.08% 15.02% $104.15
2019 $222.26B 34.97% 17.01% $115.05
2018 $164.68B -24.70% 12.66% $81.11
2017 $218.70B 12.91% 16.67% $103.69
2016 $193.69B 42.57% 14.11% $89.75
2015 $135.86B 49.50% 10.89% $61.50